IceCure reports ‘very promising’ early results in large US clinical trial, plans to present results by mid-2021
The Israeli med-tech company IceCure Medical has reported “very promising” early results in clinical trials of its innovative breast cancer treatment, which relies on a liquid nitrogen technology to freeze tumors and destroy abnormal tissue.
Give the gift of hope
We practice what we preach:
accurate, fearless journalism. But we can't do it alone.
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
- On the ground in Gaza, Syria, Israel, Egypt, Pakistan, and more
- Our program trained more than 100 journalists
- Calling out fake news and reporting real facts
Join us.
Support The Media Line. Save democracy.
The firm is nearing completion of a major clinical trial in hospitals across the United States where it has already treated hundreds of women.